Green G D
Thromb Res. 1986 Oct 15;44(2):175-83. doi: 10.1016/0049-3848(86)90133-7.
The inhibition of one- and two-chain forms of tissue-type plasminogen activator by a series of peptide derivatives of arginine chloromethyl ketone was studied. Both forms of the enzyme were inhibited by such reagents at varying rates, dependent on the peptide sequence of the inhibitor. The order of relative effectiveness of the inhibitors was the same for both one- and two-chain tissue plasminogen activator. However, an approximately ten to twenty-fold higher concentration of reagent was required with the one-chain activator to produce similar rates of inactivation. It appears that the specificity of the active sites of the one and two chain forms of tissue plasminogen activator are very similar. It is suggested that the differences in enzymatic properties of the two forms are due mainly to effects on binding (Ki) rather than on the rate of alkylation and inhibition (k2).
研究了一系列精氨酸氯甲基酮肽衍生物对单链和双链组织型纤溶酶原激活剂的抑制作用。这两种形式的酶都被此类试剂以不同速率抑制,这取决于抑制剂的肽序列。对于单链和双链组织纤溶酶原激活剂,抑制剂的相对有效性顺序相同。然而,对于单链激活剂,需要大约高10至20倍的试剂浓度才能产生相似的失活速率。看来组织纤溶酶原激活剂单链和双链形式的活性位点特异性非常相似。有人提出,这两种形式酶学性质的差异主要是由于对结合(Ki)的影响,而不是对烷基化和抑制速率(k2)的影响。